G protein coupled receptors (GPCRs) are the major hormone receptors, constituting approximately 3 percent of the human genome. It has been a dogma that, when a hormone1 binds to a GPCR, the liganded receptor activates itself to generate hormone signals (cis-activation). In contrast to this dogmatic cis-activation, the evidence is emerging that a liganded receptor molecule can intermolecularly activate nonliganded receptor molecules (trans-activation). There are only several reports on trans-activation of GPCRs: two on the thrombin receptors and our reports on the LH receptor (LHR). LHR consists of two equal halves, the extracellular N-terminal exo-domain and the membrane associated heptahelical endo-domain. Hormone binds to the exo-domain, whereas the endo-domain generates two distinct hormone signals: one for adenylyl cyclase to produce cAMP (cAMP signal) and the other for phospholipase cbeta to produce diacylglycerol and inositol phosphate (IP signal). Trans-activation is difficult to test, because it has to be differentiated from cis-activation and hormone binding needs to be distinguished from signal generation. LHR meets these requirements and offers a unique model to test trans-activation. We have established a large library of two mutant groups, one deficient in hormone binding and the other deficient in signal generation. Co-expression of a binding deficient mutant and a signal deficient mutant in a cell rescues signal generation. Our preliminary data show that the trans-activation generates either the cAMP signal or IP signal, but not both.
Aim 1 will test the hypotheses that trans-activation occurs not only to the mutant receptor pairs but also to the wild type receptor and that the signal selection is specific.
Aim 2 will define the mechanistics of the trans-activation and signal selection. These new paradigms will have broad implications on the mechanisms of GPCR signal generation and development of new receptor therapeutics, particularly to control a specific signal without invoking other signals. Receptors generate multiple signals, which is a source of undesirable/toxic side effects of hormone therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM074101-04
Application #
7479103
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Dunsmore, Sarah
Project Start
2005-08-01
Project End
2009-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
4
Fiscal Year
2008
Total Cost
$284,764
Indirect Cost
Name
University of Kentucky
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Jeoung, MyoungKun; Lee, ChangWoo; Ji, Inhae et al. (2007) Trans-activation, cis-activation and signal selection of gonadotropin receptors. Mol Cell Endocrinol 260-262:137-43
Youn, HyeSook; Jeoung, MyoungKun; Koo, YongBum et al. (2007) Kalirin is under-expressed in Alzheimer's disease hippocampus. J Alzheimers Dis 11:385-97